メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
藤田医科大学 ホーム
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
Scopus著者プロファイル
大槻 雄士
腫瘍医学研究センター
h-index
219
被引用数
6
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
2016
2025
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(10)
類似のプロファイル
(4)
フィンガープリント
Yuji Otsukiが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Pharmacology, Toxicology and Pharmaceutical Science
Abdominal Aortic Aneurysm
39%
Amino Acid
7%
Anaplastic Lymphoma Kinase Inhibitor
6%
Angina Pectoris
39%
Antioxidant
7%
Antiporter
7%
Biological Marker
34%
Cancer Mortality
6%
Carcinoma
78%
CD44v Antigen
15%
Chemotherapy
46%
Combination Therapy
13%
Cysteine
7%
Cystine
7%
Cytotoxicity
15%
Epidermal Growth Factor Receptor
6%
Everolimus
13%
Glutamate Dehydrogenase
23%
Glutamic Acid
15%
Glutamine
23%
Glutathione
7%
Granulation Tissue
39%
Head and Neck Squamous Cell Carcinoma
39%
Hypoxia
5%
Immunotherapy
6%
Inflammation
39%
Ischemia
39%
Lung Cancer
39%
Malignant Neoplasm
59%
Mammalian Target of Rapamycin Inhibitor
13%
Mouse
5%
Necrosis
39%
Neoplasm
100%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
13%
Ovary Cancer
39%
Oxyfedrine
39%
Reactive Oxygen Metabolite
7%
Recurrent Disease
6%
Stomach Cancer
39%
Stomach Tumor
5%
Sulfasalazine
31%
Trametinib
43%
Tricarboxylic Acid
7%
Medicine and Dentistry
Abdominal Aortic Aneurysm
13%
Amino Acid Transport
9%
Angina Pectoris
13%
Antioxidant
9%
Antiporter
9%
Artery
13%
Biological Marker
9%
Cancer
13%
Cancer Cell
19%
Cancer Therapy
19%
Carcinoma
39%
Catheter Ablation
9%
CD44v Antigen
19%
Cell Differentiation
9%
Cholecystectomy
13%
Citric Acid Cycle
9%
Cleft
13%
Cysteine
9%
Cystine
9%
Cytotoxicity
19%
Embolization
39%
Fallopian Tube
9%
Glutamate Dehydrogenase
29%
Glutamic Acid
19%
Glutamine
29%
Glutathione
9%
Granulation Tissue
13%
Head and Neck Squamous Cell Carcinoma
39%
Hemodialysis
39%
Ischemia
13%
Lobectomy
19%
Lung Cancer
39%
Malignant Neoplasm
9%
Mediastinal Lymph Node
6%
Metabolome Analysis
9%
Mitochondrial Respiration
9%
Necrosis
13%
Neoplasm
23%
Overall Survival
6%
Oxidative Stress
9%
Pneumonectomy
19%
Reactive Oxygen Species
9%
Retroperitoneal Lymph Node Dissection
6%
Salazosulfapyridine
39%
Segmentectomy
19%
Squamous Cell Carcinoma Cell
9%
Surgery
13%
Survival Rate
6%
Targeted Therapy
39%
Video-Assisted Thoracoscopic Surgery
39%
Keyphrases
Abdominal US
7%
Aldehyde Metabolism
39%
Angina Pectoris
7%
Bone Therapeutics
6%
Carcinoma
39%
Cellular Antioxidant
7%
Cholecystectomy
7%
Cholesterol Clefts
7%
Cholesterol Crystal Embolism
39%
Covalent Inhibitor
7%
Cysteine Content
9%
Dehydrogenase Enzyme
7%
Developmental Dynamics
7%
Drug Screen
6%
Fibrin
7%
Gallbladder
39%
Glutaminolysis
39%
Granulation Tissue
7%
GSH Content
9%
Homologous Recombination Proficient
13%
Hypertension Management
7%
Hypoxia Signaling
6%
In Vivo Environment
6%
Inflammation
7%
Inner Wall
7%
Ischemia
7%
Kit Ligand
39%
Leucophore
14%
Malignancy
7%
Muscular Layer
7%
Necrosis
7%
Needle-like
7%
Older Men
7%
Pathological Examination
7%
Pneumonectomy
7%
Progressive Resistance
13%
PubMed
7%
Redox Status
7%
Ruptured Abdominal Aortic Aneurysm (rAAA)
7%
Small Arteries
7%
Stress Therapy
9%
Systematic Mediastinal Lymph Node Dissection
9%
Trametinib
39%
Tumor
7%
U2OS
6%
